Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BIOAFFINITY TECHNOLOGIES, INC. (BIAFW)

  • SEC News
  • March 13, 2026, 12:30 UTC
  • 2
  • 1 comments

(30% Negative) BIOAFFINITY TECHNOLOGIES, INC. (BIAFW) Reports Q1 2026 Financial Results

Comment Full text

SAVARA, INC. (SVRA)

  • SEC News
  • March 13, 2026, 12:30 UTC
  • 2
  • 1 comments

(99% Neutral) SAVARA, INC. (SVRA) Announces Business Combination

Comment Full text

LIFEWARD LTD. (LFWD)

  • SEC News
  • March 13, 2026, 12:16 UTC
  • 3
  • 1 comments

(99% Neutral) LIFEWARD LTD. (LFWD) Announces Regulatory Update

Comment Full text

EQUILLIUM, INC. (EQ)

  • SEC News
  • March 13, 2026, 12:15 UTC
  • 3
  • 1 comments

(99% Neutral) EQUILLIUM, INC. (EQ) Announces Business Combination

Comment Full text

HEALTH CATALYST, INC (HCAT)

  • SEC News
  • March 13, 2026, 12:13 UTC
  • 2
  • 1 comments

Albert Benjamin 🔴 sold 70.5K shares of Health Catalyst, Inc. (HCAT) at $1.85 Transaction Date: Mar 10, 2026 | Filing ID: 000003

Comment Full text

BARINTHUS BIOTHERAPEUTICS PLC (BRNS)

  • SEC News
  • March 13, 2026, 12:03 UTC
  • 1
  • 1 comments

(10% Negative) BARINTHUS BIOTHERAPEUTICS PLC (BRNS) Reports Q1 2026 Financial Results

Comment Full text

XENETIC BIOSCIENCES, INC. (XBIO)

  • SEC News
  • March 13, 2026, 12:00 UTC
  • 1
  • 1 comments

(68% Neutral) XENETIC BIOSCIENCES, INC. (XBIO) Reports Q1 2026 Financial Results

Comment Full text

ONCOLYTICS BIOTECH INC. (ONCY)

  • SEC News
  • March 13, 2026, 12:00 UTC
  • 1
  • 1 comments

Director Parsons James T. 🟢 acquired 10.0K shares of ONCOLYTICS BIOTECH INC (ONCY) at $1.03 Transaction Date: Mar 11, 2026 | Filing ID: 009983

Comment Full text

Vicplas International LTD (569)

  • SEC News
  • March 13, 2026, 10:37 UTC
  • 1
  • 0 comments

Financial Statements and Related Announcement: Half Yearly Results

Comment Full text

TALKSPACE, INC. (TALK)

  • SEC News
  • March 13, 2026, 10:08 UTC
  • 1
  • 0 comments

New Form 10-K - Talkspace, Inc. <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001193125-26-105146 <b>Size:</b> 13 MB

Comment Full text
  • Previous
  • 24
  • 25
  • 26
  • 27
  • 28
  • Next

Search

News categories

  • Technical Exchange News(11248)
  • Event(2610)
  • SEC News(198304)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(131278)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin